Searchable abstracts of presentations at key conferences in endocrinology

ea0075d24 | Diabetes | EYES2021

Sex-specific cardioprotection of daily tadalafil in patients with type-2 diabetes. The RECOGITO, randomized, double-blind, placebo-controlled trial

Pofi Riccardo , Giannetta Elisa , Feola Tiziana , Galea Nicola , Campolo Federica , Barbagallo Federica , Badagliacca Roberto , Barbano Biagio , Ciolina Federica , Defeudis Giuseppe , Filardi Tiziana , Sesti Franz , Minnetti Marianna , Dario Vizza Carmine , Pasqualetti Patrizio , Carbone Iacopo , Francone Marco , Catalano Carlo , Pozzilli Paolo , Lenzi Andrea , Venneri Mary Anna , Gianfrilli Daniele , Isidori Andrea M.

Background: Cyclic GMP-phosphodiesterase type 5(PDE5) inhibition was shown to counteract maladaptive cardiac changes triggered by diabetes in some, but not all studies.Objective: To assess sex differences in cardiac remodeling after PDE5 inhibition in patients with diabetic cardiomyopathy.Methods: 20-week, double-blind, randomized, placebo-controlled trial (NCT01803828). 220 men and women (45-80 years) with long-duration (>3 ye...

ea0020oc4.6 | Acromegaly/IGF1/Type 2 Diabetes | ECE2009

Cardiovascular effects of chronic Sildenafil treatment in men with type 2 diabetes

Isidori Andrea , Giannetta Elisa , Carbone Iacopo , Vizza Dario , Orano Susanna , Vingolo Enzo , Bonifacio Vincenzo , Lenzi Andrea

In type 2 diabetes (T2DM), cardiomiopathy is characterized by an impairment of diastolic performance resulting in ventricular hypertrophy and dilatation. Heart remodelling leads to an increase in its angle of torsion, measurable by innovative cine-magnetic resonance imaging (MRI). To evaluate the impact of phosphodiesterase 5 inhibitors (PDE5i) on cardiovascular performance in T2DM, we designed a randomized, placebo-controlled, double blind (subject/outcome assessor) study on ...

ea0090p418 | Pituitary and Neuroendocrinology | ECE2023

Search for new biomarkers of adult growth hormone deficiency metabolic syndrome: a comprehensive overview of a four peptides analysis

Mancini Antonio , Vergani Edoardo , Bruno Carmine , Oliva Alessandro , Curro Diego

Adult growth hormone deficiency (aGHD) is characterized by an altered metabolic profile and increased cardiovascular risk. Neudesin is a newly discovered protein mainly secreted from adipose tissue and brain, under evaluation for its possible activity as negative regulator of energy expenditure. Liver expressed antimicrobial peptide (LEAP)-2 is a competitive antagonist of ghrelin on its receptor. Spexin is a polypeptide related to the galanin-kisspeptin family, secreted along ...

ea0075p08 | Pituitary and neuroendocrinology | EYES2021

Indexes of chronic low-grade inflammation in different models of insulin-resistance: Evaluation of lipocalin-2 in metabolic sindrome, partial and total growth hormone deficiency

Bruno Carmine , Vergani Edoardo , Curro Diego , Pontecorvi Alfredo , Mancini Antonio

Lipocalin-2 (LCN2) is a glycoprotein synthetized by various cell types, including neutrophils, that acts as siderophores scavenger and play an important role in different chronic inflammatory processes. Metabolic Syndrome (MetS) and Adult Growth Hormone Deficiency (AGHD), both partial and total, are characterized by inflammatory features. The objectives of our cross-sectional study were: 1) to compare LCN2 levels in these clinical pictures; 2) to evaluate the relations between...

ea0075p10 | Pituitary and neuroendocrinology | EYES2021

Hormonal adjustment to metabolic derangement in adult Growth Hormone Deficiency: evaluation of Ghrelin and LEAP-2 serum level

Vergani Edoardo , Bruno Carmine , Curro Diego , Pontecorvi Alfredo , Mancini Antonio

Background: Ghrelin and its endogenous antagonist liver-expressed antimicrobial peptide-2 (LEAP-2) are involved in GH secretion, both acting on GSH-r1α, and regulation of glucose and lipids metabolism. Metabolic impairments are often accompanied by an upregulation of LEAP-2 expression, with a usual concomitant reduction in ghrelin secretion. Adult growth hormone deficiency (aGHD), characterized by weight gain, increased fat mass and insulin resistance, represent a conditi...

ea0081ep677 | Pituitary and Neuroendocrinology | ECE2022

Role of new peptide biomarkers in metabolic profiling of adult growth hormone deficiency patients: preliminary data on neudesin and its relationship with LEAP-2

Vergani Edoardo , Bruno Carmine , Gavotti Cesare , Oliva Alessandro , Curro Diego , Mancini Antonio

Patients affected by adult growth hormone deficiency (aGHD) show worse metabolic profile, with insulin-resistance, increased total cholesterol, LDL, triglycerides, reduced HDL, and higher risk of developing type 2 diabetes mellitus and cardiovascular complications. Adult GHD and metabolic syndrome (MetS) are closely related to each other, since they share the previous depicted clinical features, while obese MetS patients display lower IGF-1 levels due to a functional reduction...

ea0070aep751 | Pituitary and Neuroendocrinology | ECE2020

Evaluation of haemolitic complement activity (ch50) and igg subclasses in adult growth hormone deficiency: Preliminary data

Vergani Edoardo , Bruno Carmine , Basile Umberto , Napodano Cecilia , Piunno Gaia , Stefanile Annunziata , Gulli Francesca , Mancini Antonio

Adult Growth Hormone Deficiency (GHD) is a condition characterized by low grade chronic inflammation; increased levels of free light chains of immunoglobulins have been described; moreover, it shares some features with metabolic syndrome (MetS), including insulin resistance and oxidative stress, but with a different pattern of antioxidant response. Finally, it is known that GH, directly or via IGF-1 activity, influences many aspects of immune response; both humoral and cellula...

ea0090p94 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Higher SHBG, Apo A1, HDL and adiponectin might be connected with lower cardiovascular risk in women with type 1 diabetes and LADA

Ljubic Spomenka , Jazbec Anamarija , Bulum Tomislav , Tomic Martina , Rahelic Dario

Aim: Low sex hormone-binding globulin (SHBG) is accompanied with onset of diabetes (DM) and increased cardiovascular risk (CVR). Proinflammatory cytokines, including adiponectin (APN) influence SHBG production. Lipid accumulation product (LAP) advocates as an indicator of increased CVR. We investigated the influence of different types of DM and sex on CVR through changes in SHBG and related risk factors.Methods: Due to the non-normal distribution of indi...

ea0070aep386 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Association of depressive symptoms and diabetes-related distress with glycemic control, self-care activities and quality of life in diabetic patients

Grgurevic Mladen , Kljajic Kristina , Gulin Tonko , Rahelic Dario

Background: Depressive symptoms (DS) and diabetes-related distress (DD) are common comorbidities in diabetic patients adversely affecting diabetes self-management and patients’ well-being.Aim: To examine associations between DS and DD with glycaemic control, quality of life and diabetes self-management.Materials and methods: Depressive symptoms, DD, quality of life, diabetes self-management and metabolic indicators were asses...

ea0013p272 | Steroids | SFEBES2007

A central physiological role for attenuated circulating DHEAS levels in aged female Rhesus Macaques?

Urbanski Henryk , Lemos Dario , Sitzmann Brandon , Garyfallou Vasilios , Kohama Steven

In humans and rhesus monkeys (Macaca mulatta) the zona reticularis of the adrenal gland produces large amounts of dehydoepiandrosterone (DHEA) and its sulfated form, DHEAS. The circulating levels of these steroids are particularly high during early adulthood, and they then decline gradually during aging, especially in females. To help elucidate the physiological function of this steroidal loss we examined the 24-hour plasma profiles of DHEAS in female rhesus monkeys, us...